Sales update second quarter 2014 Tethys Oil’s net sales

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 30, 2014 at 2:45 AM

Sales update second quarter 2014

Tethys Oil’s net sales amounted during the second quarter 2014 to MSEK 245. The average selling price during the quarter was USD 105.9 per barrel and 350,059 barrels were sold. As per 30 June 2014, the underlift position amounted to 30,105 barrels (underlift of 43,428 barrels as per 31 March 2014). All oil sales relate to Blocks 3&4 in Oman, where Tethys Oil holds 30 per cent of the licence. ┌──────────────────┬───────────────┬─────────────┬───────┬──────────┬─────────┐ │ │Net sales of │Average │Net │Production│Over-/ │ │Tethys Oil’s share│oil and gas │selling price│sales │ │underlift│ │Blocks 3&4 │ │ │ │(bbl)** │ │ │ │(MSEK) │(USD/bbl) │(bbl)* │ │(bbl)*** │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Q2 2014 │245 │105.9 │350,059│647,569 │-30,105 │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Q1 2014 │195 │106.6 │280,782│597,979 │-43,428 │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Q4 2013 │193 │108.5 │271,175│488,522 │-13,261 │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Q3 2013 │142 │102.1 │213,397│430,764 │-30,404 │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Q2 2013 │110 │107.3 │156,816│387,734 │-19,804 │ ├──────────────────┼───────────────┼─────────────┼───────┼──────────┼─────────┤ │Full year 2013 │592 │106.6 │850,926│1,663,069 │-13,261 │ └──────────────────┴───────────────┴─────────────┴───────┴──────────┴─────────┘ * After government take ** Before government take *** Volumes sold do not always correspond to Tethys Oil’s share of production after government take during a period. The difference is called over-/ underlift. The over-/underlift position is stated as per the end of each quarter. Underlift is stated as a negative number. Tethys also has some production from Lithuania. The result from the Lithuanian production is reported in the Group’s income statement as net profit/loss from associates. Six month report 2014 (January – June 2014) will be disclosed on 19 August 2014. For further information, please contact Magnus Nordin, Managing Director, phone +46 70 576 6555; magnus@tethysoil.com Morgan Sadarangani, CFO, phone +46 8 505 947 01; morgan@tethysoil.com -------------------------------------------------------------------------------- --------------------------------- Tethys Oil AB (publ) Tethys Oil is a Swedish energy company focused on exploration and production of oil and natural gas. Tethys Oil’s core area is Oman, where the company is one of the largest onshore oil and gas concession holders. Tethys Oil also has exploration and production assets onshore France and Lithuania. The shares are listed on NASDAQ OMX Stockholm (TETY) in Stockholm. Website: www.tethysoil.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...